| Emily Dean Dozier-ezell, MS, CCC-SLP | |
|
1955 22nd St, Northport, AL 35476-4250 | |
| (251) 752-3481 | |
| Not Available |
| Full Name | Emily Dean Dozier-ezell |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1955 22nd St, Northport, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770211682 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 4112 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily Dean Dozier-ezell, MS, CCC-SLP 2508 5th St, Northport, AL 35476-4732 Ph: () - | Emily Dean Dozier-ezell, MS, CCC-SLP 1955 22nd St, Northport, AL 35476-4250 Ph: (251) 752-3481 |
News Archive
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted an Orphan Drug Designation (ODD) for its lead product candidate, REOLYSIN, for the treatment of gastric cancers.
Although increased use of noninvasive positive-pressure ventilation (NIPPV) nationwide has helped decrease mortality rates among patients hospitalized with chronic obstructive pulmonary disease (COPD), a small group of patients requiring subsequent treatment with invasive mechanical ventilation (IMV) have a significantly higher risk of death than those placed directly on IMV, according to researchers in the United States who studied patterns of NIPPV use.
People with type 1 diabetes who have already been successful in achieving recommended blood sugar goals can further benefit from using continuous glucose monitoring (CGM) devices, according to results of a major multi-center clinical trial by the Juvenile Diabetes Research Foundation. Findings of the study were published online by the journal Diabetes Care.
Arrowhead Electronic Healthcare, LLC (Arrowhead) announced today its enhanced on-time, error-free guarantee program for all new ePRO projects using ePRO-LOG™ Smartphone, Web, Tablet or SMS. The guarantee specifies that the software configuration of every project will be completed per agreed upon schedule and will be free of configuration errors. If either condition is not fulfilled, customers will receive a full refund of software configuration fees upon request.
› Verified 3 days ago
Miss April F Bennett, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 507 Energy Center Blvd, Suite 301, Northport, AL 35473 Phone: 205-345-5488 Fax: 205-345-8819 | |
Dena Marie Pearson, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2201 32nd St, Northport, AL 35476 Phone: 205-339-5700 | |
Mrs. Katharine Foster Bedsole, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1955 22nd St, Northport, AL 35476 Phone: 205-319-6484 Fax: 888-826-1340 | |
Avery Morgan Elkins, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2631 Lily Way, Northport, AL 35473 Phone: 256-558-2460 | |
Mrs. Lesley Shannon Selman, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3630 Northbrook Dr, Suite D, Northport, AL 35473 Phone: 205-246-9345 | |
West Alabama Speech Pathology Services Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 507 Energy Center Blvd, Suite 301, Northport, AL 35473 Phone: 205-345-5488 Fax: 205-345-8819 | |
Margaret Slough Hass, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 507 Energy Center Blvd, Suite 301, Northport, AL 35473 Phone: 205-345-5488 |